Hillsdale Investment Management Inc.
Position in SGHT — Sight Sciences, Inc.
CIK 1368465
Toronto, A6
Position in SGHT
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$261,261
+$253,649 QoQ
Shares Held
69,300
+7118.8% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in SGHT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Hillsdale Investment Management Inc. holds $27,654,363 across 8 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BVS |
Bioventus Inc.
|
907,739 | $8,569,056 | |
| 2 | TXG |
10x Genomics, Inc.
|
216,200 | $8,289,108 | |
| 3 | INFU |
InfuSystem Holdings, Inc
|
424,473 | $4,096,164 | |
| 4 | VMD |
Viemed Healthcare, Inc.
|
225,109 | $2,566,242 | |
| 5 | NVCR |
NovoCure Ltd
|
141,900 | $2,149,785 | |
| 6 | ABT |
Abbott Laboratories
|
9,100 | $825,734 | |
| 7 | APYX |
Apyx Medical Corp
|
182,600 | $819,874 | |
| 8 | ELMD |
Electromed, Inc.
|
8,000 | $338,400 |
All Filings in SGHT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $261,261 | 69,300 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $7,612 | 960 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||